Insiders Updates
An Analysis of Atossa Therapeutics Inc (ATOS)’s Potential Price Growth
Atossa Therapeutics Inc’s filing revealed that its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0 on
Menu
Atossa Therapeutics Inc’s filing revealed that its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Atossa Therapeutics Inc’s recently made public that its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0
In a filing, Atossa Therapeutics Inc revealed its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0
Atossa Therapeutics Inc’s filing revealed that its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0 on
Atossa Therapeutics Inc’s filing revealed that its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Atossa Therapeutics Inc’s filing revealed that its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Atossa Therapeutics
Atossa Therapeutics Inc’s filing revealed that its President & CEO QUAY STEVEN C acquired Company’s shares for reported $9887.0 on